Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Buy

A

Theravance Biopharma, Inc. (TBPH)

Pharmaceutical Preparations

https://www.theravance.com

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

UGLAND HOUSE, SOUTH CHURCH STREET
GEORGE TOWN, GRAND CAYMAN, E9

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/16/2014

Market Cap

404,096,546

Shares Outstanding

49,800,000

Weighted SO

49,797,866

Total Employees

N/A

Upcoming Earnings

08/05/2024

Similar Tickers

NLTX --.--%

TIL --.--%

ACHL --.--%

NXTC --.--%

ASMB --.--%

NUVB --.--%

CTMX --.--%

SNSE --.--%

GRPH --.--%

Beta

0.2430

Last Div

0.0000

Range

7.44-11.71

Chg

0.0100

Avg Vol

430635

Mkt Cap

404096546

Exch

NASDAQ

Country

KY

Phone

6508086000

DCF Diff

0.9629

DCF

11.8329

Div Yield

0.0000

P/S

6.5159

EV Multiple

-12.9715

P/FV

2.0788

Div Yield %

0.0000

P/E

-8.8196

PEG

-0.4274

Payout

0.0000

Current Ratio

5.1995

Quick Ratio

5.1995

Cash Ratio

2.0197

DSO

84.1565

DIO

0.0000

Op Cycle

84.1565

DPO

69.7261

CCC

14.4304

Gross Margin

0.8587

Op Margin

-0.6282

Pretax Margin

-0.6163

Net Margin

-0.7362

Eff Tax Rate

-0.1944

ROA

-0.1261

ROE

-0.2129

ROCE

-0.1149

NI/EBT

1.1944

EBT/EBIT

0.9810

EBIT/Rev

-0.6282

Debt Ratio

0.1289

D/E

0.2409

LT Debt/Cap

0.1797

Total Debt/Cap

0.1941

Int Coverage

-31.2446

CF/Debt

-0.1881

Equity Multi

1.8691

Rec Turnover

4.3372

Pay Turnover

5.2348

Inv Turnover

0.0000

FA Turnover

1.5521

Asset Turnover

0.1713

OCF/Share

-0.1801

FCF/Share

-0.1970

Cash/Share

1.9710

OCF/Sales

-0.1415

FCF/OCF

1.0940

CF Coverage

-0.1881

ST Coverage

-2.0804

CapEx Coverage

-10.6388

Div&CapEx Cov

-10.6388

P/BV

2.0788

P/B

2.0788

P/S

6.5159

P/E

-8.8196

P/FCF

-42.0846

P/OCF

-45.8756

P/CF

-45.8756

PEG

-0.4274

P/S

6.5159

EV Multiple

-12.9715

P/FV

2.0788

DPS

0.0000

Latest Headlines (EST)

Benzinga Nov 19, 22:18 M&T Bank Corporation Announces Fourth Quarter Common Stock Dividend The Motley Fool Jul 06, 19:00 5 Bank Account Bonuses You Can Get With $1,000 or Less in Deposits - The Motley Fool

Revenue Product Segmentation